#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hairy cell leukaemia recurrent Pleomorphic leiomyosarcoma Hyperadrenocorticism Follicular lymphoma stage II Immunodeficiency congenital Demyelination Brain stem glioma Juvenile chronic myelomonocytic leukaemia Microvillous inclusion disease Advanced systemic mastocytosis Phenylketonuria ABO haemolytic disease of newborn Pelizaeus-Merzbacher disease Hypocalcaemia Castleman's disease More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Life with Disease Gastrointestinal stromal tumour – Diagnostics Lymphangiosarcoma – Basic Information Gaucher’s disease type III – Basic Information Rett syndrome – Diagnostics Marfan’s syndrome – Basic Information Basal cell naevus syndrome SAPHO syndrome – Basic Information Mantle cell lymphoma stage III – Treatment Mitochondrial myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Linezolid Vo659 204-NETU Azathioprine Isis 678354 Sodium Salt Rapcabtagene Autoleucel Petrelintide BRENSOCATIB Botaretigene Sparoparvovec Abc-31-116 Rifampicin Clopidogrel Hydrogen Sulfate Etoricoxib F44/10 Spartalizumab Gandotinib Afamelanotide Mitoxantrone Hydrochloride Canagliflozin Phenylephrine Hydrochloride More therapies…

    Learn about Your Condition

    Hairy cell leukaemia recurrent Pneumothorax Reperfusion injury Diarrhoea Ovarian cancer Infantile apnoea Premature rupture of membranes Fibrosarcoma metastatic Uveitis Neurotrophic keratopathy Hepatotoxicity Salivary gland cancer Cardiac failure acute Juvenile psoriatic arthritis Peritoneal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Staphylococcal bacteraemia

  • Study of cefadroxil effectiveness in adult patients with Staphylococcus aureus bloodstream infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Belgium

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Amikacin
    • Benzylpenicillin Sodium
    • Cefuroxime Sodium
    Denmark

  • Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cloxacillin
    Sweden

  • Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin
    Sweden

  • Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cefalexin
    • Cefazolin
    France Germany The Netherlands Sweden

  • Study on Reducing Antibiotic Duration for Patients with Complicated Staphylococcus aureus Bacteremia Using Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefazolin Sodium
    • Clindamycin
    • Flucloxacillin Sodium Monohydrate
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!